文献检索，用中文搜 PubMed

1

Corrigendum to "Clinicopathological Characteristics and Prognosis of Papillary Thyroid Carcinoma in Naturally Menopausal Women with Various Durations of Premenarche, Reproductive Periods, and Postmenopausal Stages".《自然绝经女性不同初潮、生育期及绝经后阶段甲状腺乳头状癌的临床病理特征及预后》勘误

Int J Endocrinol. 2018 May 2;2018:8508059. doi: 10.1155/2018/8508059. eCollection 2018.

2

Clinicopathological Characteristics and Prognosis of Papillary Thyroid Carcinoma in Naturally Menopausal Women with Various Durations of Premenarche, Reproductive Periods, and Postmenopausal Stages.不同初潮年龄、生育期及绝经后阶段时长的自然绝经女性甲状腺乳头状癌的临床病理特征及预后

Int J Endocrinol. 2017;2017:5702716. doi: 10.1155/2017/5702716. Epub 2017 Mar 3.

3

Menstrual and reproductive factors in the risk of thyroid cancer in Japanese women: the Japan Public Health Center-Based Prospective Study.日本女性甲状腺癌风险中的月经和生殖因素：基于日本公共卫生中心的前瞻性研究

Eur J Cancer Prev. 2018 Jul;27(4):361-369. doi: 10.1097/CEJ.0000000000000338.

4

Hormonal and reproductive risk factors of papillary thyroid cancer: A population-based case-control study in France.甲状腺乳头状癌的激素和生殖风险因素：法国一项基于人群的病例对照研究。

Cancer Epidemiol. 2017 Jun;48:78-84. doi: 10.1016/j.canep.2017.04.001. Epub 2017 Apr 17.

5

The role of BRAF V600E mutation as a potential marker for prognostic stratification of papillary thyroid carcinoma: a long-term follow-up study.BRAF V600E突变作为甲状腺乳头状癌预后分层潜在标志物的作用：一项长期随访研究

Endocr Res. 2014;39(4):189-93. doi: 10.3109/07435800.2013.879169. Epub 2014 Mar 28.

6

Diffuse sclerosing variant of papillary thyroid carcinoma--an update of its clinicopathological features and molecular biology.弥漫硬化型甲状腺乳头状癌——其临床病理特征和分子生物学的最新研究进展。

Crit Rev Oncol Hematol. 2015 Apr;94(1):64-73. doi: 10.1016/j.critrevonc.2014.12.001. Epub 2014 Dec 18.

7

Menstrual and reproductive factors, exogenous hormone use, and risk of thyroid carcinoma in postmenopausal women.绝经后妇女的月经和生殖因素、外源性激素使用与甲状腺癌风险。

Cancer Causes Control. 2012 Dec;23(12):2031-40. doi: 10.1007/s10552-012-0084-x. Epub 2012 Oct 23.

8

Correlation among the BRAF gene mutation status, clinicopathological features of primary tumour, and lymph node metastasizing of papillary thyroid carcinoma.BRAF基因突变状态、甲状腺乳头状癌原发肿瘤的临床病理特征与淋巴结转移之间的相关性。

Exp Clin Endocrinol Diabetes. 2014 May;122(5):268-72. doi: 10.1055/s-0034-1372624. Epub 2014 May 16.

9

BRAF mutation in follicular variant of papillary thyroid carcinoma is associated with unfavourable clinicopathological characteristics and malignant features on ultrasonography.甲状腺乳头状癌滤泡变体中的BRAF突变与不良临床病理特征及超声检查的恶性特征相关。

Clin Endocrinol (Oxf). 2014 Sep;81(3):432-9. doi: 10.1111/cen.12433. Epub 2014 Mar 13.

10

Stomatin-like protein 2 overexpression in papillary thyroid carcinoma is significantly associated with high-risk clinicopathological parameters and BRAFV600E mutation.甲状腺乳头状癌中类stomatin蛋白2的过表达与高危临床病理参数及BRAFV600E突变显著相关。

APMIS. 2016 Apr;124(4):271-7. doi: 10.1111/apm.12505. Epub 2016 Jan 11.

Suppr 超能文献

文献检索

文件翻译

深度研究

Suppr 超能文献

文献检索

文件翻译

深度研究

《自然绝经女性不同初潮、生育期及绝经后阶段甲状腺乳头状癌的临床病理特征及预后》勘误

Corrigendum to "Clinicopathological Characteristics and Prognosis of Papillary Thyroid Carcinoma in Naturally Menopausal Women with Various Durations of Premenarche, Reproductive Periods, and Postmenopausal Stages".

作者信息

机构信息

出版信息

相似文献

本文引用的文献